These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 24337597)

  • 1. Hyaluronan synthases (HAS1-3) in stromal and malignant cells correlate with breast cancer grade and predict patient survival.
    Auvinen P; Rilla K; Tumelius R; Tammi M; Sironen R; Soini Y; Kosma VM; Mannermaa A; Viikari J; Tammi R
    Breast Cancer Res Treat; 2014 Jan; 143(2):277-86. PubMed ID: 24337597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased hyaluronan content and stromal cell CD44 associate with HER2 positivity and poor prognosis in human breast cancer.
    Auvinen P; Tammi R; Kosma VM; Sironen R; Soini Y; Mannermaa A; Tumelius R; Uljas E; Tammi M
    Int J Cancer; 2013 Feb; 132(3):531-9. PubMed ID: 22753277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extensive CD44-dependent hyaluronan coats on human bone marrow-derived mesenchymal stem cells produced by hyaluronan synthases HAS1, HAS2 and HAS3.
    Qu C; Rilla K; Tammi R; Tammi M; Kröger H; Lammi MJ
    Int J Biochem Cell Biol; 2014 Mar; 48():45-54. PubMed ID: 24406795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The reciprocal association between mammographic breast density, hyaluronan synthesis and patient outcome.
    Masarwah A; Tammi M; Sudah M; Sutela A; Oikari S; Kosma VM; Tammi R; Vanninen R; Auvinen P
    Breast Cancer Res Treat; 2015 Oct; 153(3):625-34. PubMed ID: 26362804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression patterns of hyaluronan, hyaluronan synthases and hyaluronidases indicate a role for hyaluronan in the progression of endometrial cancer.
    Paiva P; Van Damme MP; Tellbach M; Jones RL; Jobling T; Salamonsen LA
    Gynecol Oncol; 2005 Aug; 98(2):193-202. PubMed ID: 15936804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High extent of O-GlcNAcylation in breast cancer cells correlates with the levels of HAS enzymes, accumulation of hyaluronan, and poor outcome.
    Tiainen S; Oikari S; Tammi M; Rilla K; Hämäläinen K; Tammi R; Kosma VM; Auvinen P
    Breast Cancer Res Treat; 2016 Nov; 160(2):237-247. PubMed ID: 27683279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronan expression in differentiated thyroid carcinoma.
    Böhm J; Niskanen L; Tammi R; Tammi M; Eskelinen M; Pirinen R; Hollmen S; Alhava E; Kosma VM
    J Pathol; 2002 Feb; 196(2):180-5. PubMed ID: 11793369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyaluronic acid synthase-1 expression regulates bladder cancer growth, invasion, and angiogenesis through CD44.
    Golshani R; Lopez L; Estrella V; Kramer M; Iida N; Lokeshwar VB
    Cancer Res; 2008 Jan; 68(2):483-91. PubMed ID: 18199543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of hyaluronan synthase 1 and distribution of hyaluronan during follicular atresia in pig ovaries.
    Miyake Y; Sakurai M; Tanaka S; Tunjung WA; Yokoo M; Matsumoto H; Aso H; Yamaguchi T; Sato E
    Biol Reprod; 2009 Feb; 80(2):249-57. PubMed ID: 18923162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of hyaluronan and hyaluronan synthase in endometrial cancer.
    Yabushita H; Kishida T; Fusano K; Kanyama K; Zhuo L; Itano N; Kimata K; Noguchi M
    Oncol Rep; 2005 Jun; 13(6):1101-5. PubMed ID: 15870928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HAS1 expression in bladder cancer and its relation to urinary HA test.
    Golshani R; Hautmann SH; Estrella V; Cohen BL; Kyle CC; Manoharan M; Jorda M; Soloway MS; Lokeshwar VB
    Int J Cancer; 2007 Apr; 120(8):1712-20. PubMed ID: 17230515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyaluronan synthase expression in ovarian cancer.
    Yabushita H; Noguchi M; Kishida T; Fusano K; Noguchi Y; Itano N; Kimata K; Noguchi M
    Oncol Rep; 2004 Oct; 12(4):739-43. PubMed ID: 15375493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor grade and matrix metalloproteinase 2 expression in stromal fibroblasts help to stratify the high-risk group of patients with early breast cancer identified on the basis of st Gallen recommendations.
    Niemiec J; Adamczyk A; Małecki K; Ambicka A; Ryś J
    Clin Breast Cancer; 2013 Apr; 13(2):119-28. PubMed ID: 23375518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered expression of hyaluronan, HAS1-2, and HYAL1-2 in oral lichen planus.
    Siponen M; Kullaa A; Nieminen P; Salo T; Pasonen-Seppänen S
    J Oral Pathol Med; 2015 Jul; 44(6):401-9. PubMed ID: 25421996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis.
    Pellikainen JM; Ropponen KM; Kataja VV; Kellokoski JK; Eskelinen MJ; Kosma VM
    Clin Cancer Res; 2004 Nov; 10(22):7621-8. PubMed ID: 15569994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Differential expression of hyaluronic acid synthase family in human bladder transitional cell carcinoma and its clinical significance].
    Cai JL; Li M; Na YQ
    Zhonghua Zhong Liu Za Zhi; 2011 Feb; 33(2):121-5. PubMed ID: 21575480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibronectin expression in carcinoma cells correlates with tumor aggressiveness and poor clinical outcome in patients with invasive breast cancer.
    Bae YK; Kim A; Kim MK; Choi JE; Kang SH; Lee SJ
    Hum Pathol; 2013 Oct; 44(10):2028-37. PubMed ID: 23684510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronan in breast cancer: correlations with nitric oxide synthases and tyrosine nitrosylation.
    Karihtala P; Soini Y; Auvinen P; Tammi R; Tammi M; Kosma VM
    J Histochem Cytochem; 2007 Dec; 55(12):1191-8. PubMed ID: 17827165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD44 expression indicates favorable prognosis in epithelial ovarian cancer.
    Sillanpää S; Anttila MA; Voutilainen K; Tammi RH; Tammi MI; Saarikoski SV; Kosma VM
    Clin Cancer Res; 2003 Nov; 9(14):5318-24. PubMed ID: 14614016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing of hyaluronan synthase 2 suppresses the malignant phenotype of invasive breast cancer cells.
    Li Y; Li L; Brown TJ; Heldin P
    Int J Cancer; 2007 Jun; 120(12):2557-67. PubMed ID: 17315194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.